Cargando…
Population-level distribution and putative immunogenicity of cancer neoepitopes
BACKGROUND: Tumor neoantigens are drivers of cancer immunotherapy response; however, current prediction tools produce many candidates requiring further prioritization. Additional filtration criteria and population-level understanding may assist with prioritization. Herein, we show neoepitope immunog...
Autores principales: | Wood, Mary A., Paralkar, Mayur, Paralkar, Mihir P., Nguyen, Austin, Struck, Adam J., Ellrott, Kyle, Margolin, Adam, Nellore, Abhinav, Thompson, Reid F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5899330/ https://www.ncbi.nlm.nih.gov/pubmed/29653567 http://dx.doi.org/10.1186/s12885-018-4325-6 |
Ejemplares similares
-
Role of in silico structural modeling in predicting immunogenic neoepitopes for cancer vaccine development
por: Zaidi, Neeha, et al.
Publicado: (2020) -
Burden of tumor mutations, neoepitopes, and other variants are weak predictors of cancer immunotherapy response and overall survival
por: Wood, Mary A., et al.
Publicado: (2020) -
Use of atropine to predict the accommodative component in esotropia with hypermetropia
por: Kothari, Mihir, et al.
Publicado: (2011) -
recountmethylation enables flexible analysis of public blood DNA methylation array data
por: Maden, Sean K, et al.
Publicado: (2023) -
Using the Beta distribution in group-based trajectory models
por: Elmer, Jonathan, et al.
Publicado: (2018)